Skip to main content
. Author manuscript; available in PMC: 2024 Mar 27.
Published in final edited form as: Explor Res Hypothesis Med. 2023 Nov 29;9(1):15–24. doi: 10.14218/ERHM.2023.00039

Table 4.

Maternal outcome within the two time periods of 14 years

Variable Total (%) Period (%) χ2-value p-value
I (n = 129) II (n = 105)
Maternal complications
 PPH 1 (0.4) 1 (0.8) 0 (0.0)
 UTI 1 (0.4) 1 (0.8) 0 (0.0)
 Acute pyelonephritis 1 (0.4) 1 (0.8) 0 (0.0)
 Anemia 4 (1.7) 2 (1.6) 2 (1.9)
 Antepartum hemorrhage 4 (1.7) 0 (0.0) 4 (3.8)
 Cervical laceration 1 (0.4) 1 (0.8) 0 (0.0)
 Chronic HTN 1 (0.4) 1 (0.8) 0 (0.0)
 Delay 2nd twin 1 (0.4) 0 (0.0) 1 (0.9) 37.01 0.008*
 Eclampsia 4 (1.7) 4 (3.1) 0 (0.0)
 Failed induction 2 (0.9) 0 (0.0) 2 (1.9)
 Failure to progress 7 (3.0) 3 (2.3) 4 (3.8)
 Malaria in pregnancy 5 (2.1) 1 (0.8) 4 (3.8)
 Obstructed haemorrhage 3 (1.3) 0 (0.0) 3 (2.8)
 Poor maternal effort 1 (0.4) 1 (0.8) 0 (0.0)
 Pre-eclampsia 2 (0.9) 2 (1.6) 0 (0.0)
 Pregnancy-induced hypertension 11 (4.7) 3 (2.3) 8 (7.6)
 Preterm labour 28 (12.0) 10 (7.8) 18 (17.1)
 Retained second twin 1 (0.4) 1 (0.8) 0 (0.0)
 Type 2 DM 1 (0.4) 1 (0.8) 0 (0.0)
None 155 (66.2)) 96 (74.4) 59 (56.2)
*

Significant p-value < 0.05.

DM, Diabetes Mellitus; HTN, Hypertension; PPH, Primary Post Partum Hemorrhage; UTI, Urinary Tract Infection.